ADVERTISEMENT
search.svg

COVID-19 Vaccines

COVID-19 Vaccines

Featured Updates

COVID-19 Vaccine Summary Chart

A reference that compares key information about the Pfizer-BioNTech, Moderna, and Janssen COVID-19 vaccines and summarizes the CDC's clinical considerations.

Adolescent COVID-19 Vaccination

The Pfizer-BioNTech COVID-19 vaccine is now authorized and recommended for the prevention of COVID-19 disease in persons 12 years of age and older. This resource answers common questions and addresses the latest clinical considerations for adolescent COVID-19 vaccination.

Third Dose of COVID mRNA vaccines

Clinical guidance from CDC on the administration of a third dose of mRNA COVID vaccines for certain immunocompromised people.

Overview

Additional Dose Recommended for Certain Immunocompromised Individuals (August 18) This resource answers frequently asked questions about additional doses of mRNA COVID-19 vaccines and summarizes key clinical considerations. (HTML) (PDF)

Providing At-Home Vaccinations (June 24)
Hear how pharmacists are expanding access to the COVID-19 vaccine by going to the patient’s home and learn about new opportunities for payment under Medicare. (Video - Slides)

CDC's Selected Adverse Events Reported after COVID-19 Vaccination has information for patients about adverse events reported after vaccination such as anaphylaxis, thrombosis with thrombocytopenia and myocarditis.

COVID-19 Vaccine Summary Chart (July 2)
Reference key information about the Pfizer-BioNTech, Moderna, and Janssen COVID-19 vaccines and the CDC's clinical considerations.

The Long-term Effects of COVID-19 Disease: Impact on Patient Care (May 13)
The long-term effects of COVID-19 are not well understood, but it is important that pharmacists are aware of how these symptoms may present in their patients. This webinar will discuss the long-term effects of COVID-19 and the advantages of COVID-19 vaccination. (APhA Open Forum Webinar - Video - Slides)

COVID-19 Vaccine Pharmacy Provider Tool (May 11)
Check this list of references and recommendations to verify that your pharmacy and staff take the necessary steps to administer COVID-19 vaccines successfully.

Reproductive Health: The Impact of COVID-19 Disease and Vaccination (April 22)
How should you talk about the COVID-19 vaccines with patients who are pregnant, breastfeeding, or contemplating pregnancy? Get tips and tools to answer questions about how COVID-19 vaccines affect reproductive health. You’ll hear the latest evidence and recommendations as well as how COVID-19 affects patients in this population. (APhA Weekly Open Forum Webinar - Video - Slides)

Public Health Partnerships in Practice (March 4)
Hear from pharmacists who have partnered with public health efforts in their communities to increase COVID-19 vaccination, reaching underserved and high-risk patient populations. (APhA Weekly Open Forum Webinar - Video - Slides)

COVID-19 Vaccine Update (February 11)
Hear breaking news, clinical considerations for special populations, and emerging processes for approval, allocation, and distribution of COVID-19 vaccines. (APhA Weekly Open Forum Webinar - Video - Slides)

CDC's Understanding the Federal Retail Pharmacy Program for COVID-19 Vaccination details the collaboration program between the federal government, states and territories, and 21 national pharmacy partners and independent pharmacy networks. Reference this summary chart Pharmacy Partnership Programs for COVID-19 Vaccination for more information.

NEJM's COVID-19 Vaccine Resource Center is a collection of information, research, and Frequently Asked Questions.

CDC's COVID-19 Vaccination is a collection of resources intended to help healthcare providers prepare to vaccinate patients.

 
Frontline Perspectives

Student Pharmacist Involvement in COVID-19 Vaccination (January 21)
Hear about successes and barriers to student involvement in COVID-19 vaccination efforts. Whether you are a faculty member at a school of pharmacy, a practicing pharmacist who works with students, or a student pharmacist, gain practical insights from this webinar in collaboration with the American Association of Colleges of Pharmacy! (APhA Weekly Open Forum Webinar - Video - Slides)

COVID-19 Vaccine Frontline Perspectives (January 7)
Hear frontline pharmacists discuss COVID-19 vaccination logistical considerations, implementation strategies, key administration information, and other factors that facilitate successful vaccine administration. (APhA Weekly Open Forum Webinar - Video - Slides)

 

CDC's VaccineFinder Public Display Checklist for Pharmacies using the COVID Locating Health Provider Portal provides instructions for VaccineFinder.org, a national resource of COVID-19 vaccine providers to help consumers find provider locations that carry COVID-19 vaccines near them and learn how to make an appointment.

CDC's Post Vaccine Considerations for Healthcare Personnel provides strategies to manage systemic signs and symptoms after vaccination.

 
Storage and Administration

Maximizing COVID-19 Vaccine Doses (June 23)
Recommendations for vaccine withdrawal and administration techniques to decrease variability between doses. (APhA Know the Facts - PDF)

Understanding Dead Space (February 1)
Learn the steps you can take to maximize the number of available COVID-19 vaccine doses. Join us as we explain the concept of dead space, why it matters, and what you can do to minimize it, and finally review techniques to ensure that you are getting as many doses of COVID-19 vaccine out of each vial. (APhA 15 on COVID-19 - CPE Video)

COVID-19 Vaccine Storage and Logistics (October 8)
Get the latest information about unique storage considerations for the COVID-19 vaccines in development as well as handling and other logistics in working with the community to help increase patient access. (APhA Weekly Open Forum Webinar - Video - Slides)

 

USP's COVID-19 Vaccine Handling Toolkit provides strategies that help increase vaccinations while supporting safe handling and quality.

CDC's Vaccine Administration Resource Library provides videos and references for vaccine providers including information on needle gauge and length, I.M. injection adults 19 years of age and older, and I.M. injection children 7-18 years of age.

 
Documentation and Billing

Reimbursement for Administration of COVID-19 Vaccine(s)—What We Know (June 21)
This resource provides an overview of what we know about COVID-19 vaccine reimbursement at this time and covers steps pharmacists can take now to be positioned as a COVID-19 vaccine provider. (APhA Know the Facts - PDF)

CMS's Medicare Payment for COVID-19 Vaccination Administration in the Home has important updates on increased reimbursement for at-home COVID-19 vaccinations.

HRSA COVID-19 Uninsured Program and Coverage Assistance Fund: Updates for Pharmacy (June 4)
This resource provides an overview of what we know about COVID-19 vaccine reimbursement at this time and covers steps pharmacists can take now to be positioned as a COVID-19 vaccine provider. (APhA Know the Facts - PDF)

CDC's VaxText COVID-19 Vaccination Second-Dose Reminder is a free messaging program that providers can recommend to patients.

 

Monitoring COVID-19 Vaccine Safety: VAERS and V-SAFE (December 10)
Hear from Tanya Myers, PhD, MSc, the v-safe team lead for the CDC, as she provides a brief overview of two vaccine safety monitoring platforms pharmacists should be aware of. (APhA Weekly Open Forum Webinar Excerpt - Video - Slides)

 

Viral Vector COVID-19 Vaccines

Adenovirus Vector Technology (March 3)

We examine how adenovirus-based vaccines work, answer some of the common questions that patients may be asking, and look at the history of adenovirus-based vaccines. (APhA 15 on COVID-19 - CPE Video)

Johnson & Johnson Single-dose Janssen COVID-19 Vaccine (February 25)

Get a comprehensive overview of the available data on the Johnson & Johnson COVID-19 vaccine’s effectiveness and safety. (APhA Open Forum Webinar - Video - Slides)

CDC's Understanding and Explaining Viral Vector COVID-19 Vaccines provides background and safety information about these vaccines for healthcare professionals.

NEJM's Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine summarizes the preliminary data available for the Johnson & Johnson vaccine. (January 13)

CDC issued a health alert (April 13) regarding cases of a rare type of blood clot in individuals after receiving the Janssen (J&J) COVID-19 vaccine. The alert includes recommendations for clinicians that pharmacists should be aware of.

Janssen COVID-19 Vaccine (J&J) Overview—What Pharmacists Need to Know (March 18)
Join us for an overview of the Janssen (J&J) COVID-19 vaccine as we review the mechanism of action, efficacy and safety data, storage and handling information, and vaccine hesitancy data. This one-stop program will cover everything you need to know about the vaccine. (APhA 15 on COVID-19 - CPE Video)

 
 

mRNA COVID-19 Vaccines

CDC's Clinical Considerations for Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults provides background on this reported adverse events and recommendations for clinicians.

Breaking COVID-19 Updates (December 17)
Hear breaking COVID-19 vaccine updates on approvals, administration factors, and dissemination strategies from vaccine experts. (APhA Weekly Open Forum Webinar - Video - Slides)

Key Points About COVID-19 Vaccines (December 11)
This resource summarizes key information to help pharmacists and their team address common questions. Hang up this handout in the pharmacy or give it to patients! (APhA Know the Facts - PDF)

Breaking News on COVID-19 Vaccines: Part 2 (December 10)
Hear from CDC representatives about the latest information about how to prepare for COVID-19 vaccination and vaccine safety monitoring. (APhA Weekly Open Forum Webinar - Video- Slides)

Breaking News on COVID-19 Vaccines: Part 1 (December 3)
As the first COVID-19 vaccines make their way closer to reaching the public, APhA keeps you up to date on the latest information from vaccine safety to distribution strategies. (APhA Weekly Open Forum Webinar -Video - Slides)

mRNA Vaccines (July 24)
This episode looks at the new mRNA vaccine technology, and look at the early data to see if they are a viable option for preventing COVID-19. (APhA 15 on COVID-19 - CPE)

  • Self-Attestation Statements for COVID-19 Recipients: Download or edit a patient attestation form from the options below to provide to patients requesting an additional dose of mRNA COVID-19 vaccine.
    1. Detailed patient attestation using patient friendly definition of moderately or severely immunocompromised individuals(PDF)(Word)
    2. Concise patient attestation for moderately or severely immunocompromised individuals(PDF)(Word)
    3. Detailed patient attestation using formal definition of moderately or severely immunocompromised individuals (PDF)(Word)
 
Moderna

Moderna COVID-19 Vaccine (mRNA-1273) (February 10)
This overview of the Moderna vaccine (mRNA-1273) covers the mechanism of action, efficacy, and safety data; storage and handling information; and vaccine hesitancy data. This one-stop program will cover everything you need to know about the vaccine. (APhA 15 on COVID-19 - CPE Video)

The Moderna COVID-19 Vaccine: What Pharmacists Need to Know (December 23)
Following the emergency authorization of the Moderna COVID-19 vaccine, we spoke with two pharmacy vaccine experts to talk about what it means for pharmacists. (APhA Locked on Pharmacy Podcast - Podcast)

CDC's Moderna COVID-19 Vaccine provides administration and storage information, as well as clinical considerations.

FDA's Moderna COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers and for Recipients and Caregivers (as of December 18)

Pfizer-BioNTech

The Pfizer-BioNTech Vaccine: What Pharmacists Need to Know (December 13)
Following the emergency authorization of the Pfizer-BioNTech COVID-19 vaccine, we spoke with two pharmacy vaccine experts to talk about what it means for pharmacists. (APhA Locked on Pharmacy Podcast - Podcast)

Pfizer-BioNTech COVID-19 Vaccine Overview (December 10)
New, free 1-hour CPE is a comprehensive overview of the information that pharmacists need about the Pfizer-BioNTech COVID-19 vaccine: mechanism of action; review of efficacy and safety data; storage; handling; dose preparation/administration; EUA authorization requirements for vaccine providers; and tips to address vaccine hesitancy. (APhA Education During COVID-19 - CPE)

CDC's Pfizer-BioNTech COVID-19 Vaccine provides administration and storage information, as well as clinical considerations.

FDA's Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers and for Recipients and Caregivers. (as of February 25)

FDA's COVID-19 Update: FDA Allows More Flexible Storage, Transportation Conditions for Pfizer-BioNTech COVID-19 Vaccine (February 25)

NEJM's BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting studies the real-world efficacy of the Pfizer-BioNTech vaccine. (February 24)

Adolescent COVID-19 Vaccination

Adolescent COVID-19 Vaccination (July 2) Reference this FAQ about the use and safety of the Pfizer-BioNTech COVID-19 vaccine in individuals ages 12-15 years old. (APhA Know the Facts – PDF)

CDC's Pediatric Healthcare Professionals COVID-19 Vaccination Toolkit collects resources to inform conversations with parents/guardians.

CDC's Covid-19 Vaccines for Children and Teens is an informative webpage you can share with patients.

CDC's Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States – Vaccination of Children and Adolescents outlines guidance on obtaining appropriate assent and reminds providers of the risk of syncope after injection.

FDA's Pfizer-BioNTech COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers and for Recipients and Caregivers should be provided to parents/guardians after adolescent vaccination.

 

Key Links

Testing in Pharmacies

COVID-19 Vaccines

Immunizing during COVID-19

Managing your Pharmacy

Telehealth

Advocacy Opportunities

Well-being

Compounding

Medications Being Studied

All COVID-19 Resources